Skip to main content
ABION Inc. logo

ABION Inc. - Investor Relations & Filings

Listed IPO Sep 2021
Ticker · 203400 ISIN · KR7203400007 KO Professional, scientific and technical activities
Open in API
Filings indexed 419 across all filing types
Latest filing 2026-07-06 Director's Dealing
Country KR South Korea
Listing KO 203400 · 1 venue

Key figures FY2025

Period ended 2025-12-31 · KRW
Headline annual figures for ABION Inc., fiscal year 2025, reported in KRW, with the source filing for each figure.
Total Revenues KRW 880.14M per the Audit Report / Information filed 2026-03-19
Net Income KRW -29.06B per the Audit Report / Information filed 2026-03-19
Total Assets KRW 80.57B per the Audit Report / Information filed 2026-03-19
Total Equity KRW 68.36B per the Audit Report / Information filed 2026-03-19
Cash from Ops KRW -33.04B per the Audit Report / Information filed 2026-03-19

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About ABION Inc.

https://abionbio.com/en/

ABION Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative medicines, focusing on first-in-class and best-in-class therapeutics for oncology and viral diseases. The company's lead oncology asset is ABN401, a selective c-Met tyrosine kinase inhibitor (TKI) designed to treat non-small cell lung cancer (NSCLC) with MET mutations, which has shown a favorable safety profile. Another key pipeline candidate is ABN501, a novel monoclonal antibody targeting Claudin-3 for various cancers. Beyond oncology, ABION is developing ABN101, a second-generation Interferon-β formulated as a broad-spectrum anti-viral inhaler for respiratory infections. The company aims to commercialize its assets in global markets through internationally recognized clinical processes.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주특정증권등소유상황보고서) filed in South Korea. This type of filing is a mandatory regulatory disclosure for insiders (directors, executives, and major shareholders) to report changes in their shareholdings. In the context of the provided categories, this falls under 'Director's Dealing' (DIRS), as it details the personal share transactions (specifically '장내매수' or on-market purchase) by an executive (Woo Sung Yoon).
2026-07-06 Korean
최대주주변경을수반하는주식담보제공계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure regarding a 'Pledge of Shares' (stock collateral agreement) by the company's largest shareholder. This type of filing is a standard corporate disclosure required by financial regulators (such as the DART system in Korea) to inform the market about potential changes in control or financial risk associated with major shareholdings. It does not fit into specific categories like earnings, dividends, or M&A, and is best classified as a general regulatory filing.
2026-07-03 Korean
주식병합결정
Share Issue/Capital Change Classification Held out of the broad gpt-era re-classification: filing ingested <48h ago, so a realtime re-analysis could re-fire a filing.processed webhook. Prior label kept. 2026-07-04.
2026-07-02 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification Held out of the broad gpt-era re-classification: filing ingested <48h ago, so a realtime re-analysis could re-fire a filing.processed webhook. Prior label kept. 2026-07-04.
2026-07-02 Korean
주주총회소집결의 (임시주주총회)
Proxy Solicitation & Information Statement Classification Held out of the broad gpt-era re-classification: filing ingested <48h ago, so a realtime re-analysis could re-fire a filing.processed webhook. Prior label kept. 2026-07-04.
2026-07-02 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1,294 characters) notifying stakeholders of an upcoming Investor Relations (IR) meeting. It provides the date, time, location, and purpose of the event, and mentions where the IR materials will be posted. According to the 'Menu vs Meal' rule and the definition for Report Publication Announcement (RPA), which covers announcements inviting stakeholders to an upcoming investor presentation or event, this document is classified as an RPA.
2026-06-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.